Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)
Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE)
Clinical trial of BAY43-9006 in patients with hepatocellular carcinoma.
Inclusion Criteria:
Exclusion Criteria:
Sunto, Shizuoka 411-8777, Japan
Chuo-ku, Tokyo 104-0045, Japan
Itabashi-ku, Tokyo 173-8610, Japan
Meguro-ku, Tokyo 152-8902, Japan
Minato-ku, Tokyo 105-8470, Japan
Nerima-ku, Tokyo 177-8521, Japan
Shinjuku-ku, Tokyo 160-0023, Japan